Effect of tetrahydroaminoacridine on cognition,function and behaviour in Alzheimer's disease.

OBJECTIVE: To determine the efficacy of tetrahydroaminoacridine (THA) in Alzheimer''s disease. DESIGN: Randomized, double-blind, multiple crossover trial with three treatment periods, each consisting of 3 weeks of active drug therapy and 3 weeks of placebo administration. SETTING: Referral-based geriatric practice in a community hospital. PATIENTS: Thirty-four patients with moderate to severe Alzheimer''s disease. Subjects were included if they had stage 3 to 6 disease (as determined by the Reisberg scale) and had not been taking psychotropic drugs for at least 1 month and if informed consent had been obtained from the patients and their next of kin. INTERVENTIONS: Fifty to 100 mg of THA daily and matched placebo. RESULTS: Of the initial 34 patients 14 experienced liver toxicity and 3 gastrointestinal side effects during the study; however, all 22 who completed the study were able to tolerate at least the minimum dose. For the 22 patients there was no clinically or statistically significant effect of THA on cognition, functional status or behaviour. The results for individual patients showed no subgroup of THA-responsive patients. CONCLUSION: THA has no clinically important benefits in Alzheimer''s disease and is associated with appreciable toxic effects.     

Analysis in vivo of translational mutants of the rIIB cistron of bacteriophage T4

We have mapped the mutants isolated by Nelson et al. (1981) that reduce the amount of rIIB protein synthesized during bacteriophage T4 infection of Escherichia coli B and characterized their rIIB expression in vivo. These mutants fall into four distinct groups in terms of mapping and phenotype. We have located the probable site of each mutation on the DNA sequence. We have also analyzed a number of other mutations near the initiating AUG of rIIB with respect to their rIIB expression. In some of these mutants, ribosomal recognition of the wild-type initiating AUG is precluded and so initiation occurs at a different AUG, which, in some instances, we have identified.     

Bacillus sphaericus for the control of mosquitoes

From 1972 to 1977 a large laboratory effort was devoted to determining data on efficacy, safety, environmental impact (on nontarget organisms), and some preliminary field work using several isolates of Bacillus sphaericus. The B. sphaericus strains were found to be specific in their mosquito larvicidal activity, not causing mammalian toxicity nor apparent perturbation of the environment. During this period several fermentation and industrialization problems were investigated so that by 1978, using new strains and cultures, it was possible to have prepared kilogram amounts of an active dry stable powder, of strain 1593, for field evaluation. These field evolution. These field evaluations are presently still in progress. Control has been seen particularly against Culex, Anopheles, and Psorophora species, with some what less control aganst Aedes species. Unlike the agriculturally oriented Bacillus thuringiensis candidates, B. sphaericus bacterial cell, which is digested in the larval midgut (within a peritrophic membrane), releasing a toxin as early as 15 min after ingestion. Subsequent death of the larva ensues. Recent evidence suggests that applied B. sphaericus powder will survive in aquatic situations (ditches, ponds, and tree holes) for at least nine month. Comparisons of the B. sphaeicus strains with recently isolated strains of B. thuringiensis (var. israelensis), the latter being particularly active against Aedes species, indicates that they may be useful complements of each other in overall mosquito control strategies. The recent isolation of several new strains of B. thuringiensis, from WHO-CCBC accessions from Roumania, indicate that although the B. thuringiensis isolate is a rare event when compared to the occurrence of B. sphaericus isolates (they usually occur together in accessions from which B. thuringiensis is isolated), several new useful strains of B. thuringiensis should be anticipated. The longevity of the B. thuringiensis strains in the wild has not yet been investigated.     

Effects of tetracyclines on aldosterone- and insulin-mediated Na+ transport in the toad urinary bladder

The effect of oxytetracycline and demethylchlortetracycline on aldosterone- and insulin-mediated Na⁺ transport (short-circuit current) were examined in toad urinary bladders mounted in modified Ussing chambers. Oxytetracycline had little or no effect on either basal or aldosterone-mediated Na⁺ transport. In contrast, demethylchlortetracycline markedly inhibited both basal and aldosterone-mediated Na⁺ transport. Furthermore, demethylchlortetracycline inhibited the aldosterone response significantly out of proportion to its effects on basal Na⁺ transport. Neither of the drugs had an effect on insulin-mediated Na⁺ transport. Consequently, the natriuresis observed in certain patients treated with demethylchlortetracyline may be related to drug-induced renal resistance to the effects of aldosterone.     

The participation of alpha-actinin in the capping of cell membrane components.

By means of double fluorescence staining experiments, intracellular alpha-actinin was found to accumulate under caps and patches induced in several cells by a variety of ligands. This phenomenon was demonstrated in lymphocytes and lymphoma cells treated with anti-H-2 sera; spleen lymphocytes treated with concanavalin A or anti-immunoglobulin antibodies, and VSV-infected mouse fibroblast line MC57 treated with antiserum against viral antigens. It occurred during both rapid and slow capping processes, and could be obtained by either direct or indirect ligand-induced redistribution. These observations were carried out on whole cells. For other cytoskeletal proteins such as filamin, tropomyosin and myosin, a similar accumulation under caps was not readily apparent using whole cell mounts, although earlier experiments with frozen-sectioned cells had shown such an enrichment of myosin (as well as actin). The enrichment of alpha-actinin under the clustered surface molecules was already apparent in early stages (patching) of the capping process, with or without 10 mM sodium azide present. Prolonged incubation of the cells with the different ligands resulted in endocytosis of the ligand-receptor complex. alpha-Actinin was not associated with the inernalized complex, however, suggesting that it may dissociate from the patched or capped surface structures at some stage during endocytosis.